Eugene Marcantonio
Chief Executive Officer at ARMGO Pharma, Inc.
Eugene Marcantonio active positions
| Companies | Position | Start | End |
|---|---|---|---|
ARMGO Pharma, Inc.
 ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Director/Board Member | 2017-09-30 | - |
| Chief Executive Officer | 2020-12-31 | - | |
| Chief Tech/Sci/R&D Officer | 2017-03-31 | 2020-12-31 | |
| President | 2017-03-31 | 2020-12-31 |
Career history of Eugene Marcantonio
Training of Eugene Marcantonio
| New York University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 3 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
ARMGO Pharma, Inc.
ARMGO Pharma, Inc. Pharmaceuticals: MajorHealth Technology ARMGO Pharma, Inc. discovers and develops novel small-molecule therapeutics. Its product include Rycal Science is an inspiring new direction in therapy for the leading causes of morbidity and mortality; Rycals are small-molecule therapeutics developed in the laboratory. The company was founded in 2004 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Eugene Marcantonio
- Experience
